No Data
No Data
JMP Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $4
Wedbush Initiates Werewolf Therapeutics(HOWL.US) With Buy Rating, Announces Target Price $8
Promising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects
Analysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)
Express News | HC Wainwright & Co. Reiterates Buy on Werewolf Therapeutics, Maintains $15 Price Target
Unlocking Broader Therapeutic Potential: Andrew Fein's Buy Rating on Werewolf Therapeutics